Although uncommon, cardioversion does have risks. The procedure can sometimes worsen arrhythmias. Rarely, it can cause life-threatening arrhythmias. These irregular heartbeats are treated with electrical shocks or medicines.
Cardioversion can dislodge blood clots in the heart. These clots can travel to organs and tissues in the body and cause a stroke or other problems. Taking anticlotting medicines before and after cardioversion can reduce this risk.
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Cardioversion, visit www.clinicaltrials.gov.
September 2, 2014
Gary H. Gibbons
Researcher Brings Medicine One Step Closer to Widely Available Cure for Sickle Cell Disease
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.